AI-Crafted mRNA vaccine takes on advanced cancers in first human trial
NCT ID NCT07560943
First seen May 03, 2026 · Last updated May 18, 2026 · Updated 4 times
Summary
This early-stage trial tests a personalized mRNA cancer vaccine designed by artificial intelligence. It is given as a shot directly into tumors for people with advanced solid cancers who have run out of standard options. The main goal is to check safety and find the right dose, while also watching for any signs that the vaccine shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The West China Hospital
RECRUITINGChengdu, Sichuan, 646000, China
-
West China Hospital
NOT_YET_RECRUITINGChengdu, Sichuan, 610000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.